Literature DB >> 24425709

Are concerns about reliability in the trial to assess chelation therapy fair grounds for a hasty dismissal?: An alternative perspective.

Sanjay Kaul1.   

Abstract

Keywords:  Bayes theorem; Editorials

Mesh：

Substances：

Year:  2014        PMID： 24425709     DOI： 10.1161/CIRCOUTCOMES.113.000714

Source DB:  PubMed          Journal:  Circ Cardiovasc Qual Outcomes        ISSN： 1941-7713


× No keyword cloud information.
  5 in total

Review 1.  Chronic Toxic Metal Exposure and Cardiovascular Disease: Mechanisms of Risk and Emerging Role of Chelation Therapy.

Authors:  Ehimen C Aneni; Esteban Escolar; Gervasio A Lamas
Journal:  Curr Atheroscler Rep       Date:  2016-12       Impact factor: 5.113

Review 2.  EDTA Chelation Therapy to Reduce Cardiovascular Events in Persons with Diabetes.

Authors:  Pamela Ouyang; Sheldon H Gottlieb; Valerie L Culotta; Ana Navas-Acien
Journal:  Curr Cardiol Rep       Date:  2015-11       Impact factor: 2.931

Review 3.  Edetate Disodium-Based Treatment for Secondary Prevention in Post-Myocardial Infarction Patients.

Authors:  Gervasio A Lamas; Omar M Issa
Journal:  Curr Cardiol Rep       Date:  2016-02       Impact factor: 2.931

Review 4.  Chelation therapy to treat atherosclerosis, particularly in diabetes: is it time to reconsider?

Authors:  Gervasio A Lamas; Ian Ergui
Journal:  Expert Rev Cardiovasc Ther       Date:  2016-05-05

Review 5.  Chelation therapy after the trial to assess chelation therapy: results of a unique trial.

Authors:  Maria D Avila; Esteban Escolar; Gervasio A Lamas
Journal:  Curr Opin Cardiol       Date:  2014-09       Impact factor: 2.161
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.